BREAST CANCER RESEARCH NEWS: WHAT YOU NEED TO KNOW October 2020
Textured Implants May Be Linked to Breast Cancer Recurrence A South Korean study of 650 women found that those who had textured implants for reconstruction after breast cancer surgery had a small but statistically significant increase in the risk of the breast cancer coming back.
Verzenio for Early-Stage Breast Cancer and Risk Reduction Adding Verzenio to hormonal therapy after surgery to remove early-stage hormone-receptor-positive, HER2-negative breast cancer with a high risk of recurrence lowers that recurrence risk by about 25%, according to early
results from the monarchE study. Read
Trodelvy Improves Outcomes for Previously Treated Metastatic Triple-Negative Breast Cancer Compared to chemotherapy, the immune targeted therapy Trodelvy offered better progression-free survival and better overall survival for people with metastatic triple-negative breast
cancer that had been previously treated with chemotherapy, according to the phase III ASCENT trial. Read
Research Spotlight: ESMO 2020 Virtual Congress Get a breakdown of the biggest headlines from the European Society for Medical Oncology annual meeting. Our podcast episode explains the SOLAR-1 trial that looked at specific PIK3CA-mutated breast cancers, studies to treat early-stage hormone-receptor-positive HER2-negative breast cancer, and more. Listen
How Chemotherapy Choice Could Affect the Use of Tecentriq for Breast Cancer A study showed that combining Tecentriq and Abraxane improved overall survival compared to Abraxane alone for people diagnosed with metastatic PD-L1-positive triple-negative breast cancer, while another trial found that combining Tecentriq with Taxol was no better than Taxol alone in treating the same cancer type. Listen
You subscribed to received updates. If you no longer wish to be notified, unsubscribe here.
Breastcancer.org, 120 East Lancaster Ave, Suite 201, Ardmore, PA 19003, United States Breastcancer.org is a nonprofit 501(c)(3) organization.
